November 6th 2024, 10:00pm
By Spencer Feldman
Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.
November 6th 2024, 8:00pm
By Alex Biese
The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.
November 6th 2024, 6:00pm
By Linda Cohen
My quality of life has improved a lot after starting on a BTK inhibitor, but some things will never be the same — like being in crowded places without a mask!
November 6th 2024, 4:00pm
By Ashley Chan
Patients with EGFR-mutant non-small cell lung cancer who are TKI-naïve benefited from receiving the Cyramza-Tagrisso combination versus Tagrisso alone.
November 6th 2024, 2:00pm
Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.
November 5th 2024, 10:00pm
Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.
November 5th 2024, 8:00pm
Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.
November 5th 2024, 6:00pm
By Karen Cohn
Even if care teams have all of your information on their end, advocating for yourself is still necessary during cancer treatment.
November 5th 2024, 4:00pm
Patients with cervical cancer demonstrated better sexual health and quality of life after undergoing simple hysterectomies versus radical hysterectomies.
November 5th 2024, 2:00pm
The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.
November 4th 2024, 10:00pm
By Darlene Dobkowski, MA
Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in early data from a phase 3 trial.
November 4th 2024, 8:00pm
Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with minimal side effects.
November 4th 2024, 6:00pm
By Ron Cooper
I once thought that prostate cancer should be the center of my universe, but with everything else going on, now I’m not so sure.
November 4th 2024, 5:29pm
By Joseph F. Renzulli MD, FACS
Panelists discuss how the diagnosis and treatment of advanced prostate cancer can significantly impact intimacy and relationships, emphasizing the importance of open communication about goals and preferences in treatment decisions, while also sharing strategies for self-advocacy and maintaining quality of life (QOL) throughout the treatment journey.
Panelists discuss how various support groups and resources for patients with advanced prostate cancer can provide essential guidance and community, while sharing personal experiences on finding and using these valuable tools throughout their treatment journey.
CR&T Honors Dr Richard T. Silver with its Humanitarian Award
CPAN News Bulletin – October 2024
Triage Cancer Hosts Final 2024 Conference
The Importance of Precision Medicine: The Next Frontier in Treatment